Details for New Drug Application (NDA): 074223
✉ Email this page to a colleague
The generic ingredient in GLIPIZIDE is glipizide; metformin hydrochloride. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the glipizide; metformin hydrochloride profile page.
Summary for 074223
Tradename: | GLIPIZIDE |
Applicant: | Watson Labs Teva |
Ingredient: | glipizide |
Patents: | 0 |
Suppliers and Packaging for NDA: 074223
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GLIPIZIDE | glipizide | TABLET;ORAL | 074223 | ANDA | Actavis Pharma, Inc. | 0591-0460 | 0591-0460-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0591-0460-01) |
GLIPIZIDE | glipizide | TABLET;ORAL | 074223 | ANDA | Actavis Pharma, Inc. | 0591-0460 | 0591-0460-05 | 500 TABLET in 1 BOTTLE, PLASTIC (0591-0460-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Feb 27, 1995 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Feb 27, 1995 | TE: | AB | RLD: | No |
Complete Access Available with Subscription